YTHDF2 and neoplasm: METTL14 is also decreased in colorectal cancer and represses tumor progression by promoting SOX4 expression and reducing XIST in an m6A-YTHDF2-dependent manner, and by promoting pri-miR-375 processing through an m6A/DGCR8-dependent mechanism.